Drug intelligence / Profile preview

cefazolin + metronidazole

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Cefazolin + metronidazole is a combination of two antibiotics commonly used for surgical prophylaxis, especially in clean-contaminated procedures such as abdominal, gynecological, and obstetric surgeries. Cefazolin is a first-generation cephalosporin that acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis. Metronidazole is a nitroimidazole antibiotic that acts as a prodrug; it inhibits nucleic acid synthesis in anaerobic bacteria and protozoa by forming reactive nitroso radicals that disrupt microbial DNA. The combination provides broad-spectrum coverage against both aerobic (mainly Gram-positive) and anaerobic organisms. Clinical studies have shown this regimen reduces postoperative infection rates and hospital stays compared to cefazolin alone[1][2][5].

Other names
cefazoline + metronidazolecephazolin + metronidazole
02

Targets

PBP (Penicillin-binding protein family)bacterial dsDNA (Bacterial double-stranded DNA)

Beyond the preview

Go deeper on cefazolin + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefazolin + metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call